Medicon Valley Biomedical Newsletter

7TM Pharma A/S has announced that they have acquired CareX SA, a privately held French company based in Strasbourg, France. CareX specializes in discovery of small molecule drugs for the treatment of ...

ALK-Abelló A/S has received approval from the US FDA to conduct a clinical study, RT-01, in the US with a tablet-based allergy vaccine against ragweed under an Investigational New Drug application. ...

Bavarian Nordic A/S expects an expanding cooperation with US governmental authorities on the approval and marketing of new vaccines, including IMVAMUNE smallpox vaccine as well as the company's HI...

Celltrix AB has signed a EUR 3 million agreement with Novo A/S and SEED Capital Denmark K/S. The two new owners ensure financial support for completion of clinical trials and market introduction of Ce...

Egalet A/S has announced the signing of a long-term manufacturing agreement with SP Medical A/S Under the terms of the agreement, SP Medical will manufacture sufficient clinical grade quantitie...

Gambro Healthcare has announced that it has started operations in Lithuania by acquiring 11 clinics with about 300 patients. Gambro Healthcare will through this major acquisition broaden its market pr...

Genmab A/S has announced it has initiated a Phase III pivotal study with HuMax-CD20 (ofatumumab) to treat patients with refractory B-cell Chronic Lymphocytic Leukemia, CLL. HuMax-CD20 received a Fast ...

The transplantation clinic at Danish Rigshospitalet has placed an order to buy Glycorex Transplantation AB's product Glycosorb, developed for use at transplants between patients of different blood...

The breast cancer drug Tamoxifen is well tested and often very efficient pharmaceutical against breast cancer. The drug has been used for more than 25 years and has been used as a post-operational sup...

MediCult A/S has signed and closed an agreement with Laboratorios LETI S.L. Unipersonal, LETI, its long term distributor in Spain and a leading pharmaceutical company within the allergy field. Accordi...

MediCult A/S has signed an agreement with Auckland-based KODE Biotech Ltd., KBL, securing it exclusive rights to KBL's KODE technology for Assisted Reproduction Technologies, ART, media applicatio...

Medtentia AB has received EUR 430,000 from the existing investors in an intermediate financing round. The financial support will secure the completion of the evaluation of the preclinical studies in o...

Novozymes A/S has signed an agreement to acquire UK-based Delta Biotechnology Ltd. from the Sanofi-Aventis group. The acquisition is subject to the usual official approvals and is expected to be final...

Osteologix, A/S has announced the completion of a reverse merger and share exchange transaction with publicly-held Castle & Morgan Holdings, Inc. (OTC) based in New York, NY. Concu...

A team of researchers from Biotech Research & Innovation Centre, BRIC, University of Copenhagen, has revealed how cancer cells, in popular terms, stay forever young. But there is still hope....

SchizoDetect AB has received EUR 170,000 from five business angels from the network of Connect Skåne. The founding will secure the completion of the first instruments with the built-in technique to de...

TopoTarget A/S and CuraGen corp. have announce the initiation of patient dosing in a National Cancer Institute sponsored Phase II clinical trial evaluating the activity of PXD101, a small molecule his...

TopoTarget A/S has exercised its option to purchase under the agreement entered into December 2005 with BioImage A/S. That gives TopoTarget full ownership of TOP216 which is an mTOR anticancer drug pr...

TopoTarget A/S and CuraGen Corporation have announced the initiation of patient dosing in a Phase I clinical trial evaluating the safety and tolerability of PXD101, a small molecule histone deacetylas...